Dr. Crystal Hattum is a pharmacist who is specialized in Oncology in Sioux Falls, South Dakota. Patients can reach her at 1000 E 23rd St, Sioux Falls or contact her on 605-322-3893. Active license number of Dr. Crystal Hattum is 6496 for Oncology in South Dakota. Dr. Crystal Hattum is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Crystal Hattum speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Crystal Hattum
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
1000 E 23rd St, Sioux Falls, South Dakota, 57105-2108
Phone:
605-322-3893
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Crystal Hattum are as mentioned below.
NPI Number:
1518681436
NPI Enumeration Date:
04 Oct, 2022
NPI Last Update On:
04 Oct, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Crystal Hattum are as mentioned below.
Specialization
License Number
State
Status
Oncology
6496
South Dakota
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1325 S Cliff Ave, Sioux Falls, South Dakota
Zip:
57105-1007
Phone Number:
605-322-3893
Fax Number:
--
Patients can reach Dr. Crystal Hattum at 1000 E 23rd St, Sioux Falls, South Dakota or can call on phone at 605-322-3893.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.